Form D · Biotechnology
MI:RNA Ltd
Edinburgh, X0 · CIK 0001984052
Offering snapshot reported Nov 18, 2024 · SEC filing
- Reported sold
- $4.43M Offering amount: $4.43M
- Investors reported
- 57 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2024 | Initial | $4,433,698 | No comparison | 57 | SEC filing |
| Aug 1, 2023 | Initial | $295,997 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529671
Source: Form D, filed Nov 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Axe | Director |
| Neil Clelland | Director |
| N/A Gabriel Investments Limited | Director |
| Eve Hanks | Director |
| Huw Jones | Director |
| Alexandra Lusty | Director |
| Colin Hugh Macewan | Director |
| Kathryn Mac Kinnon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Scotland's Rural College Room 16 Peter Wilson Building Basement
Edinburgh, X0, EH9 3JG
Edinburgh, X0, EH9 3JG